الفهرس | Only 14 pages are availabe for public view |
Abstract Summary and Conclusion he term DSD was proposed for congenital conditions in which chromosomal, gonadal or anatomical sex is atypical. In general, factors influencing sex determination are transcriptional regulators, whereas factors important for sex differentiation are secreted hormones and their receptors. At each stage of the life of the DSD patient and his family, new symptoms and malfunctions arise, affecting the balance of the system. Although the psychological outcome of DSD is often satisfactory, many medical and psychosocial factors may put the development of children with DSD in many ways at risk. Clinical decisions, the timing of interventions and the way medical information is communicated have farreaching consequences for one’s quality of life. Also newborns with ambiguous genitalia pose a difficult emotional situation for parents in deciding their future sexual orientation. Moreover, these parents also face a social nightmare explaining to their relatives and friends, the gender reassignment. The current intense debate on the management of patients with intersexuality and related conditions focus on four major issues: 1) Etiological diagnosis. 2) Assignment of gender. 3) Indication for and timing of genital surgery. 4) The disclosure of medical information to the patient and his/her parents. The goals of therapy include a surgical outcome with a good cosmetic appearance and functionality with potential for sexual intercourse with sufficient sensitivity for satisfactory responsiveness. Psychological care should be provided from birth with gradual transition primarily to the patient. Optimal care for children with DSD requires an experienced multidisciplinary team which is generally found in tertiary care centers. Ideally, the team includes pediatric subspecialists in endocrinology, surgery or urology or both, psychology, gynecology, genetics, neonatology, and, if available, social work, nursing, and medical ethics. The physicians involved in intersex clinical management have a responsibility to respect patient autonomy, patient disclosure, and informed consent. They also have an ethical obligation to pursue the patient’s best interests while promoting universal human rights. In addition, the physician managing families of DSD patients could minimize the trauma of having a child of unidentified sex by providing appropriate genetic counseling so that the parents can make an early decision. Prenatal DNA testing in at-risk families should be considered, and appropriate therapy offered to minimize or prevent genital ambiguity. Currently available outcome studies of patients with DSDs have limitations because of multiple factors, including lack of representative patient sampling, and lack of adequate information concerning both medical and surgical care, as well as psychological, social and family support. The discussion on respect and tolerance towards individuals with DSDs must continue around the globe. In discussing the issues on a global scale; biological, psychological, sociological, anthropological, legal, and cultural factors must be considered. The medical profession must regularly provide up-todate information and findings on biological and medical issues for individuals to make responsible decisions in their personal lives. Finally, Individuals within various social institutions and cultures need to be more accepting of individual differences; the laws, both nationally and internationally, need to provide greater protections to all human as a matter of preserving human integrity and dignity. |